Human Health Holdings Limited (1419.HK)
HKD 0.78
(0.0%)
HKD 0.78
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.34 Million | 664.26 Million | 295.81 Million | 85.49 Million | 37.49 Million | 50.7 Million |
| Net Income | 24.18 Million | 180.83 Million | 375.3 Million | 144.45 Million | -40.37 Million | 26.62 Million |
| Depreciation & Amortization | 68.21 Million | 74.79 Million | 63.07 Million | 67.59 Million | 75.33 Million | 12.18 Million |
| Deferred income taxes | - | -310.61 Million | 194.3 Million | 209.86 Million | 2.15 Million | 5.61 Million |
| Stock-based compensation | - | 14 Thousand | 68 Thousand | 227 Thousand | 185 Thousand | 602 Thousand |
| Change in working capital | 20.43 Million | 310.6 Million | -194.37 Million | -210.09 Million | -2.38 Million | -6.21 Million |
| Other non-cash items | -24.18 Million | 408.63 Million | -142.56 Million | -126.55 Million | 2.53 Million | 11.89 Million |
| Investing Cash Flow | -47.63 Million | -335.34 Million | -203.21 Million | -4.77 Million | -18.98 Million | -69.04 Million |
| Investments in PPE | -39.5 Million | -84.02 Million | -76.51 Million | -14.05 Million | -11.46 Million | -8.6 Million |
| Acquisitions | 17 Thousand | 58 Thousand | 135 Thousand | 329 Thousand | 109 Thousand | -562 Thousand |
| Investment purchases | -7.34 Million | -250.13 Million | -126.47 Million | -650 Thousand | -10.41 Million | -57.67 Million |
| Sales/Maturities of investments | - | 250.07 Million | 10.36 Million | 10.36 Million | 10.3 Million | 8.84 Million |
| Other Investing Activities | -803 Thousand | -251.32 Million | -10.71 Million | -759 Thousand | -7.52 Million | -11.04 Million |
| Financing Cash Flow | -122.65 Million | -178.28 Million | -67.44 Million | -59.3 Million | -64.74 Million | -1.49 Million |
| Debt repayment | -4.96 Million | -50.78 Million | -49.63 Million | -51.99 Million | -55.29 Million | -9.49 Million |
| Dividends payments | -60.72 Million | -113.86 Million | -45.54 Million | -542 Thousand | -10.84 Million | -10.84 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -56.96 Million | -13.63 Million | 27.73 Million | -6.76 Million | 1.39 Million | 18.84 Million |
| Accounts receivables | 58.7 Million | 320.51 Million | -189.94 Million | -208.12 Million | -2.9 Million | -1.18 Million |
| Accounts payables | -5.71 Million | 16.98 Million | 6.18 Million | 15.07 Million | -11.99 Million | 5.66 Million |
| Inventory | -4.41 Million | -9.91 Million | -4.42 Million | -1.97 Million | 521 Thousand | -5.03 Million |
| Other working capital | -28.13 Million | -16.98 Million | -6.18 Million | -15.07 Million | 11.99 Million | -5.66 Million |
| Cash at beginning of period | 295.1 Million | 145.72 Million | 120.75 Million | 98.75 Million | 145.16 Million | 165.44 Million |
| Cash at end of period | 295.1 Million | 295.1 Million | 145.72 Million | 120.75 Million | 98.75 Million | 145.16 Million |
| Capital Expenditure | -39.5 Million | -84.02 Million | -76.51 Million | -14.05 Million | -11.46 Million | -8.6 Million |
| Effect of forex changes on cash | - | -1.26 Million | -174 Thousand | 584 Thousand | -178 Thousand | -444 Thousand |
| Net cash flow / Change in cash | - | 149.37 Million | 24.97 Million | 22 Million | -46.41 Million | -20.27 Million |
| Free Cash Flow | -28.16 Million | 580.24 Million | 219.29 Million | 71.43 Million | 26.03 Million | 42.09 Million |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.15 Million | 20.03 Million | -87.27 Million | 180.83 Million | 268.11 Million | 375.3 Million |
| Depreciation & Amortization | 34.99 Million | 33.11 Million | 38.99 Million | 74.79 Million | 35.89 Million | 63.07 Million |
| Deferred income taxes | - | - | -95.34 Million | -310.61 Million | -59.96 Million | 194.3 Million |
| Stock-based compensation | - | - | 6000.00 | 14 Thousand | 8000.00 | 68 Thousand |
| Change in working capital | 6.02 Million | 21.98 Million | 211.08 Million | 310.6 Million | 115.88 Million | -194.37 Million |
| Other non-cash items | -4.15 Million | -111.84 Million | -79.4 Million | 408.63 Million | -18.32 Million | -142.56 Million |
| Investing Cash Flow | -66.85 Million | 19.22 Million | -214.7 Million | -335.34 Million | -120.64 Million | -203.21 Million |
| Investments in PPE | -13.15 Million | -26.35 Million | -47.81 Million | -84.02 Million | -36.2 Million | -76.51 Million |
| Acquisitions | - | 17 Thousand | 58 Thousand | 58 Thousand | - | 135 Thousand |
| Investment purchases | -7.34 Million | - | -165.71 Million | -250.13 Million | -84.42 Million | -126.47 Million |
| Sales/Maturities of investments | -45.94 Million | 45.94 Million | - | 250.07 Million | - | 10.36 Million |
| Other Investing Activities | -417 Thousand | 45.57 Million | -1.22 Million | -251.32 Million | -17 Thousand | -10.71 Million |
| Financing Cash Flow | -30.12 Million | -93.45 Million | -31.11 Million | -178.28 Million | -145.68 Million | -67.44 Million |
| Debt repayment | -1.73 Million | -25.56 Million | -2.8 Million | -50.78 Million | -2.89 Million | -49.63 Million |
| Dividends payments | -82 Thousand | -60.64 Million | -30 Thousand | -113.86 Million | -113.83 Million | -45.54 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -28.3 Million | -7.24 Million | -32.02 Million | -13.63 Million | -6.74 Million | 27.73 Million |
| Accounts receivables | 5.41 Million | 53.28 Million | 189.58 Million | 320.51 Million | 130.93 Million | -189.94 Million |
| Accounts payables | -2.85 Million | -2.86 Million | 11.75 Million | 16.98 Million | 5.23 Million | 6.18 Million |
| Inventory | 35 Thousand | -4.45 Million | 1.09 Million | -9.91 Million | -11.01 Million | -4.42 Million |
| Other working capital | 3.42 Million | -26.85 Million | 8.65 Million | -16.98 Million | -9.27 Million | -6.18 Million |
| Cash at beginning of period | 184.2 Million | 193.91 Million | 289.71 Million | 145.72 Million | 146.73 Million | 120.75 Million |
| Cash at end of period | 184.2 Million | 184.2 Million | 193.91 Million | 295.1 Million | 289.71 Million | 145.72 Million |
| Capital Expenditure | -13.15 Million | -26.35 Million | -47.81 Million | -84.02 Million | -36.2 Million | -76.51 Million |
| Effect of forex changes on cash | - | 51 Thousand | -812 Thousand | -1.26 Million | -448 Thousand | -174 Thousand |
| Net cash flow / Change in cash | - | -9.7 Million | -95.8 Million | 149.37 Million | 142.97 Million | 24.97 Million |
| Free Cash Flow | 35.82 Million | -63.06 Million | 160.01 Million | 580.24 Million | 418.73 Million | 219.29 Million |
LU7
6492
CGFEF
3OY1
INDXTRA
1849